203 related articles for article (PubMed ID: 10688431)
1. Early increase in urinary leukotriene E4 (LTE4) is dependent on allergen dose inhaled during bronchial challenge in asthmatic subjects.
Bancalari L; Conti I; Giannessi D; Lazzerini G; Dente FL; De Caterina R; Paggiaro PL
Allergy; 1999 Dec; 54(12):1278-85. PubMed ID: 10688431
[TBL] [Abstract][Full Text] [Related]
2. The challenge procedure influences the extent of allergen-induced urinary excretion of leukotriene E4.
Kumlin M; Dahlén B
Clin Exp Allergy; 2000 Apr; 30(4):585-9. PubMed ID: 10718858
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions.
O'Sullivan S; Roquet A; Dahlén B; Dahlén S; Kumlin M
Clin Exp Allergy; 1998 Nov; 28(11):1332-9. PubMed ID: 9824404
[TBL] [Abstract][Full Text] [Related]
4. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo.
Diamant Z; Timmers MC; van der Veen H; Friedman BS; De Smet M; Depré M; Hilliard D; Bel EH; Sterk PJ
J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):42-51. PubMed ID: 7822663
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of leukotriene E4 and eosinophil protein X in children with atopic asthma.
Severien C; Artlich A; Jonas S; Becher G
Eur Respir J; 2000 Oct; 16(4):588-92. PubMed ID: 11106196
[TBL] [Abstract][Full Text] [Related]
6. Urinary leukotriene E4 in patients with asthma. Effect of airways reactivity and sodium cromoglycate.
Westcott JY; Smith HR; Wenzel SE; Larsen GL; Thomas RB; Felsien D; Voelkel NF
Am Rev Respir Dis; 1991 Jun; 143(6):1322-8. PubMed ID: 1646581
[TBL] [Abstract][Full Text] [Related]
7. Urinary LTE4 is higher after nasal provocation test with L-ASA in bronchial than in only nasal responders.
Micheletto C; Visconti M; Tognella S; Trevisan F; Dal Negro RW
Eur Ann Allergy Clin Immunol; 2007 May; 39(5):162-6. PubMed ID: 17626331
[TBL] [Abstract][Full Text] [Related]
8. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma.
Sestini P; Armetti L; Gambaro G; Pieroni MG; Refini RM; Sala A; Vaghi A; Folco GC; Bianco S; Robuschi M
Am J Respir Crit Care Med; 1996 Feb; 153(2):572-5. PubMed ID: 8564100
[TBL] [Abstract][Full Text] [Related]
9. Contrasting effects of allergen challenge on airway responsiveness to cysteinyl leukotriene D(4) and methacholine in mild asthma.
Ketchell RI; D'Amato M; Jensen MW; O'Connor BJ
Thorax; 2002 Jul; 57(7):575-80. PubMed ID: 12096198
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of fluticasone and montelukast on allergen-induced asthma.
Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J
Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
[TBL] [Abstract][Full Text] [Related]
11. Urinary leukotriene E4 levels during early and late asthmatic responses.
Manning PJ; Rokach J; Malo JL; Ethier D; Cartier A; Girard Y; Charleson S; O'Byrne PM
J Allergy Clin Immunol; 1990 Aug; 86(2):211-20. PubMed ID: 2166758
[TBL] [Abstract][Full Text] [Related]
12. Urinary leukotriene E4 in bronchial asthma.
Smith CM; Hawksworth RJ; Thien FC; Christie PE; Lee TH
Eur Respir J; 1992 Jun; 5(6):693-9. PubMed ID: 1321055
[TBL] [Abstract][Full Text] [Related]
13. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics.
Kumlin M; Dahlén B; Björck T; Zetterström O; Granström E; Dahlén SE
Am Rev Respir Dis; 1992 Jul; 146(1):96-103. PubMed ID: 1320824
[TBL] [Abstract][Full Text] [Related]
14. Changes in urinary LTE4 and nasal functions following nasal provocation test with ASA in ASA-tolerant and -intolerant asthmatics.
Micheletto C; Tognella S; Visconti M; Trevisan F; Dal Negro RW
Respir Med; 2006 Dec; 100(12):2144-50. PubMed ID: 16678396
[TBL] [Abstract][Full Text] [Related]
15. Urinary leukotriene E4 after lysine-aspirin inhalation in asthmatic subjects.
Christie PE; Tagari P; Ford-Hutchinson AW; Black C; Markendorf A; Schmitz-Schumann M; Lee TH
Am Rev Respir Dis; 1992 Dec; 146(6):1531-4. PubMed ID: 1333741
[TBL] [Abstract][Full Text] [Related]
16. Urinary leukotriene E4 levels after allergen and exercise challenge in bronchial asthma.
Smith CM; Christie PE; Hawksworth RJ; Thien F; Lee TH
Am Rev Respir Dis; 1991 Dec; 144(6):1411-3. PubMed ID: 1660231
[TBL] [Abstract][Full Text] [Related]
17. Increased urinary LTE4 excretion following inhalation of LTC4 and LTE4 in asthmatic subjects.
Christie PE; Tagari P; Ford-Hutchinson AW; Black C; Markendorf A; Schmitz-Schumann M; Lee TH
Eur Respir J; 1994 May; 7(5):907-13. PubMed ID: 8050548
[TBL] [Abstract][Full Text] [Related]
18. Allergen-induced early and late asthmatic responses to inhaled seasonal and perennial allergens.
Boulet LP; Gauvreau G; Boulay ME; O'Byrne PM; Cockcroft DW
Clin Exp Allergy; 2015 Nov; 45(11):1647-53. PubMed ID: 26115509
[TBL] [Abstract][Full Text] [Related]
19. Effect of altitude on urinary leukotriene (LT) E4 excretion and airway responsiveness to histamine in children with atopic asthma.
Christie PE; Yntema JL; Tagari P; Ysselstijn H; Ford-Hutchinson AW; Lee TH
Eur Respir J; 1995 Mar; 8(3):357-63. PubMed ID: 7789477
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005.
Hamilton AL; Watson RM; Wyile G; O'Byrne PM
Thorax; 1997 Apr; 52(4):348-54. PubMed ID: 9196518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
